Endocrine Abstracts

Background: Acromegaly is a severe systemic condition characterized by elevated circulating levels of growth hormone (GH) and insulin-like growth factor I (IGF-I) and increased mortality and morbidity. The role of GH and IGF-I in mammary hyperplasia is well established and GH/IGF-I elevation has been hypothesized to favor neoplastic development. We recently demonstrated that premenopausal females with active acromegaly may display an increased mammographic breast density (MBD)...

The impact of GH/IGF-1 levels on skeletal muscle in patients with acromegaly is still matter of debate. Recently, temporal (TMT) and masseter muscle thickness (MMT) have emerged as reliable indicators of muscle mass, as well as patients’ functional status/prognosis in various clinical context – especially in the oncologic setting. This study aims to investigate the potential correlations between TMT/MMT and patients’ demographic and clinical characteristics. A r...